Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
Delayed Japan Exchange  -  05/27 02:00:00 am EDT
3429.00 JPY   -0.46%
05/26Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-related Macular Degeneration Associated with Subfoveal Choroidal Neovascularization and Diabetic Macular Edema
AQ
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CHUGAI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend

12/29/2021 EDT
share with twitter
share with LinkedIn
share with facebook

A final dividend is removed today from Chugai Pharmaceutical Co., Ltd.'s share.



© Factset 2021
All news about CHUGAI PHARMACEUTICAL CO., LTD
05/26Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-relat..
AQ
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares a..
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted ..
PU
04/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
04/26Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
04/26Nikkei 225 Up 0.4% on Wall Street Cues, Softer Interest Rates, Oil Outlook
MT
04/26Chugai Pharmaceutical Logs 178% Surge in Q1 Net Income on Higher Sales
MT
04/25CHUGAI PHARMACEUTICAL : 1Q Results (Jan-Mar 2022)
PU
04/25Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 20..
AQ
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
More recommendations
Financials
Sales 2022 1 187 B 9 320 M 9 320 M
Net income 2022 343 B 2 690 M 2 690 M
Net cash 2022 604 B 4 742 M 4 742 M
P/E ratio 2022 16,5x
Yield 2022 2,26%
Capitalization 5 665 B 44 487 M 44 487 M
EV / Sales 2022 4,26x
EV / Sales 2023 4,74x
Nbr of Employees 7 664
Free-Float 37,8%
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3 445,00 JPY
Average target price 4 677,69 JPY
Spread / Average Target 35,8%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-7.76%44 487
JOHNSON & JOHNSON4.90%472 231
PFIZER, INC.-8.57%302 932
ROCHE HOLDING AG-12.16%282 336
ELI LILLY AND COMPANY13.48%282 164
ABBVIE INC.11.20%266 074